GlaxoSmithKline
GSK
#194
Rank
$83.67 B
Marketcap
$40.66
Share price
-0.34%
Change (1 day)
8.86%
Change (1 year)

GlaxoSmithKline (GSK) Fails to deliver data

Key failure to deliver metrics for GlaxoSmithKline:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for GlaxoSmithKline (GSK) - 3 month history

Number of shares, 3 month chart

Biweekly Failures to deliver volume for GlaxoSmithKline (GSK) - since 2022

Volume in USD (price x number of shares), data since 2022

GlaxoSmithKline (GSK) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024$15.11 M-49.44%
2023$29.9 M-43.98%
2022$53.37 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3months) FTD volume (1 year) Country
$14.81 M$86.48 M๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$36.43 M$0.32 B๐Ÿ‡บ๐Ÿ‡ธ USA
$26.04 M$54.23 M๐Ÿ‡ซ๐Ÿ‡ท France
$22.72 M$0.19 B๐Ÿ‡บ๐Ÿ‡ธ USA
$0.10 B$0.17 B๐Ÿ‡ฌ๐Ÿ‡ง UK
$6.42 M$44.32 M๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
$0.27 M$4.96 M๐Ÿ‡บ๐Ÿ‡ธ USA